share_log

Cantor Fitzgerald Maintains Overweight on Cresco Labs, Lowers Price Target to $15

Cantor Fitzgerald Maintains Overweight on Cresco Labs, Lowers Price Target to $15

坎託·菲茨傑拉德維持對Cresco Labs的增持,將目標股價下調至15美元
Benzinga Real-time News ·  2022/08/18 04:30

Cantor Fitzgerald analyst Pablo Zuanic maintains Cresco Labs (OTC:CRLBF) with a Overweight and lowers the price target from $19 to $15.

坎託·菲茨傑拉德分析師巴勃羅·祖安尼克維持Cresco Labs(場外交易代碼:CRLBF)增持,並將目標股價從19美元下調至15美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論